Click it and Unblock the Notifications
Latest Updates
-
As ‘Ranabaali’ Hits Theatres, A Look At Rashmika Mandanna’s ₹1.31 Lakh Ivory Saree For Pre-Release Promotions -
Durga Puja Pandals Mumbai 2026: 7 Stunning Celebrations To Explore From Matunga To Juhu -
World Spine Day 2026: Is Your Phone Habit Causing Neck Pain? What To Know About Tech Neck -
Breast Cancer Awareness Month 2026: Expert Explains Why Family History Isn't the Only Risk -
Skanda Sashti 2026: Significance, Vrat Rituals And How Devotees Observe The Day -
Saraswati Avahan 2026: Significance, Shubh Muhurat, Rituals And Puja Vidhi -
Navratri Day 6: Maa Katyayani Puja, Colour, Rituals, And Significance -
Garba Before The DJ Era: What Navratri Looked Like In Earlier Times -
What Does Indian Design Mean Today? A Creative Director Explains -
Why Your Vision Can Feel Different In Bright And Dim Rooms, Expert Explains
St. John's Wort May Not Treat ADHD In Kids
Researchers at Bastyr University, Kenmore, Washington, have found that kids and teens with attention-deficit/hyperactivity disorder (ADHD) who were treated with the herb St. John's wort did not have any greater improvement in ADHD symptoms as compared to those who received a placebo.
For the study, Wendy Weber, N.D., Ph.D., M.P.H., of Bastyr University, Kenmore, Wash., and colleagues conducted a clinical trial of St. John's wort (Hypericum perforatum) on 54 kids and teens with ADHD, age 6 to 17 years, to determine whether this agent was effective in lessening the severity of ADHD symptoms.
During the study, 27 participants were randomly assigned to receive 300 mg of H perforatum standardized to 0.3 percent hypericin (a compound derived from H perforatum) and 27 participants received a matched placebo, three times daily for eight weeks.
The study showed that there were no significant differences between the two groups in the change in ADHD rating scale scores from the start of the trial to week 8 and in change in scores rating inattentiveness and hyperactivity.
Researchers found that there was also no difference in the proportion of participants who were rated as much or very much improved regarding ADHD symptoms on another measurement scale.
No statistically significant difference was found between the two groups in the proportion of participants who experienced 1 or more rash, nausea/vomiting, headache, or sunburn during the trial.
"To our knowledge, this is the first placebo-controlled trial of H perforatum in children and adolescents. The results of this study suggest that administration of H perforatum has no additional benefit beyond that of placebo for treating symptoms of child and adolescent ADHD," the authors said.
The study is published in the June 11 issue of JAMA.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google
